Cogstate introduces ORCA suite for early Alzheimer's detection

Studies in preclinical and emergent Alzheimer’s disease indicate that learning deficits emerge well in advance of any impairment in episodic memory (Lim, 2020). Consequently, identification of these learning deficits in otherwise cognitively unimpaired older adults could provide a critical tool for the identification of very early AD and for assessing the effects of AD drugs at this early stage of the disease. In this context, Cogstate is delighted to announce the addition of the Objective Retention-based Cognitive Assessment (ORCA) suite of learning tests to our platform, allowing learning to be assessed and analyzed with rigor, precision, and accuracy. Visit our team at booth #1610 during #AAIC25 Toronto to experience the demo. Learn more about how Cogstate’s digital endpoint solutions enable clearer signal detection – book a meeting with our team during AAIC: https://buff.ly/5ptij3f

  • No alternative text description for this image
John Harrison

Chartered Psychologist and author

1mo

I'll swing by the stand Cogstate. J

Jennifer Sullivan

Clinical Trials Leader | Global Rater Network Strategist | Cognitive Science Enthusiast | Champion of Quality Data & Cross-Team Collaboration | Lifelong Learner & Part-Time Genealogy Sleuth

1mo

Very cool!

Like
Reply
See more comments

To view or add a comment, sign in

Explore content categories